HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Primary Immune Thrombocytopenia
October 29, 2026
manilatimes.net
[Crypto Investor Who Bet on DeFi Says China Crackdown May Help It] To continue, please click the box below to let us know you’re not a robot. Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review our [Terms of Service](/notices/tos) and [Cookie Policy](/notices/tos) .…
